| ZFIN ID: ZDB-EXP-231025-10 |
Experiment Conditions Description: chemical treatment by injection: kainate(1-), chemical treatment by environment: levetiracetam
| chemical treatment by injection: kainate(1-) |
|---|
| Name: | chemical treatment by injection |
|---|---|
| Synonyms: | |
| Definition: | Chemical treatment in which the chemical is injected into the zebrafish. |
| Ontology: | Zebrafish Environment Condition Ontology [ZECO:0000237] |
| Name: | kainate(1-) |
|---|---|
| Synonyms: | kainate |
| Definition: | A dicarboxylate resulting from deprotonation of both carboxy groups of kainic acid, and protonation of its amine group. Major species at pH 7.3. |
| Ontology: | ChEBI [CHEBI:156548] ( EBI ) |
| chemical treatment by environment: levetiracetam |
|---|
| Name: | chemical treatment by environment |
|---|---|
| Synonyms: | |
| Definition: | Chemical treatment condition in which the chemical is introduced through the environment. For zebrafish this is the tank water. |
| Ontology: | Zebrafish Environment Condition Ontology [ZECO:0000238] |
| Name: | levetiracetam |
|---|---|
| Synonyms: | (-)-(S)-alpha-ethyl-2-oxo-1-pyrrolidineacetamide, (2S)-2-(2-oxopyrrolidin-1-yl)butanamide, (S)-(-)-alpha-ethyl-2-oxo-1-pyrrolidineacetamide, (S)-alpha-ethyl-2-oxo-1-pyrrolidineacetamide, Keppra, levetiracetam, levetiracetamum, UCB-L 059 |
| Definition: | A pyrrolidinone and carboxamide that is N-methylpyrrolidin-2-one in which one of the methyl hydrogens is replaced by an aminocarbonyl group, while another is replaced by an ethyl group (the S enantiomer). An anticonvulsant, it is used for the treatment of epilepsy in both human and veterinary medicine. |
| Ontology: | ChEBI [CHEBI:6437] ( EBI ) |
| Publication: | Heylen et al., 2021 |
|---|